GlassScriptPhysician profile
Mallory Peters
NPI 1811566151
$1,598.13
in general payments reported to CMS, 2019-2025
10 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.60 · 2023: $31.76 · 2024: $268 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $499.41 | 2024-2025 | Trumatch |
| Inspire Medical Systems, INC. | $427.52 | 2024-2025 | Inspire |
| Axogen | $344.09 | 2025 | Axoguard Ha+ Nerve Protector |
| Aerin Medical INC. | $153.66 | 2025 | |
| Cochlear Americas | $80.23 | 2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Biocryst US Sales Co., LLC | $27.55 | 2024 | Orladeyo |
| Tempus Ai, INC | $21.31 | 2024 | Xt Cdx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.79 | 2023 | Ofev |
| Astrazeneca Pharmaceuticals LP | $14.97 | 2023 | Tezspire |
| Ormco Corporation | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.